Integrated ultrasound radiomics and clinical data to predict PD-1 blockade efficacy in unresectable hepatocellular carcinoma
Dong Jiang, Zonghan Liu, Kang Wang, Yi Qian, Jinkai Feng, Lin Gong, Jialun Ren, Yanjun Xiang, Fangfang Zhang, Liheng Liu, Hongkun Zhou, Chao Liang, Wenjing Wei, Boyang Zang, Chui Kong, Yiran Li, Shuqun Cheng · 2025
Read Integrated ultrasound radiomics and clinical data to predict PD-1 blockade efficacy in unresectable hepatocellular carcinoma by Dong Jiang, Zonghan Liu, Kang Wang, Yi Qian, Jinkai Feng, Lin Gong, Jialun Ren, Yanjun Xiang, Fangfang Zhang, Liheng Liu, Hongkun Zhou, Chao Liang, Wenjing Wei, Boyang Zang, Chui Kong, Yiran Li, Shuqun Cheng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12784509.txt.
Description
Dong Jiang and a large team of co-authors build a tool, published in twenty twenty-five, to predict who will respond to immune therapy for liver cancer that cannot be cut out. The therapy blocks the PD-1 protein, freeing immune cells to attack the tumor. It helps some patients much more than others.
The team mixed features read from ultrasound images with routine clinical data. They trained the model on a large group drawn from several centers, then tested it on a smaller group followed forward in time. The mixed model beat the image-only model at telling responders from non-responders. Tests on liver tissue helped explain why some tumors resist. The authors aim to spare non-responders a treatment unlikely to help.
Catalog record
| CREATOR | Dong Jiang, Zonghan Liu, Kang Wang, Yi Qian, Jinkai Feng, Lin Gong, Jialun Ren, Yanjun Xiang, Fangfang Zhang, Liheng Liu, Hongkun Zhou, Chao Liang, Wenjing Wei, Boyang Zang, Chui Kong, Yiran Li, Shuqun Cheng |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |